primary hffs (ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
Primary Hffs, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary hffs/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Stimulation of neutral lipid synthesis via viral growth factor signaling and ATP citrate lyase during vaccinia virus infection"
Article Title: Stimulation of neutral lipid synthesis via viral growth factor signaling and ATP citrate lyase during vaccinia virus infection
Journal: Journal of Virology
doi: 10.1128/jvi.01103-24
Figure Legend Snippet: VACV stimulates neutral lipid droplet formation in primary HFFs. ( A ) Role of neutral lipids in cellular metabolism. The enzyme ACLY converts cytoplasmic citrate, generated by the TCA cycle from glucose or glutamine, into acetyl-CoA and oxaloacetate. Acetyl-CoA can be further utilized for lipid synthesis, and neutral lipid synthesis via a series of reactions catalyzed by the enzymes ACC, FASN, ACAT, and DGAT. The fig was created with BioRender.com. ( B ) VACV infection stimulates the formation of neutral lipid droplets. HFFs were infected with VACV at an MOI of 5 for 8 h. Lipid droplets were stained with HCS Lipidtox Red, and the nuclei were stained with DAPI and imaged under a confocal microscope ( n ≥ 3). ( C ) The intensities of the red signals corresponding to the lipid droplets in were quantified in the bar graph using ImageJ. ( D ) VACV infection increases the lipid droplet-associated protein PLIN2 levels in HFFs. HFFs were infected with WT VACV at an MOI of 5 for 8 h. Western blotting analysis was performed to measure the levels of PLIN2. ( E ) VACV infection-induced lipid droplet formation is cell-type specific. HepG2 and A549 cells were infected with VACV at an MOI of 5 for 8 h. Lipid droplets were stained with HCS Lipidtox Red, and the nuclei were stained with DAPI and imaged under a confocal microscope ( n ≥ 3). ( F ) The intensities of the signals corresponding to the lipid droplets in were quantified in the bar graph. ( G ) VACV infection does not alter the levels of PLIN2 in HepG2 and A549 cells. The cells were infected with WT VACV at an MOI of 5 for 8 h. Western blotting analysis was performed to measure the levels of PLIN2. For P values, ns, P > 0.05; ** P ≤ 0.01; *** P ≤ 0.001. **** P ≤ 0.0001. In D and G, representative images of multiple biological replicates were shown. The numbers below each band indicate the average intensities of respective proteins as calculated by ImageJ. The relative average intensities ± standard deviation of PLIN2/GAPDH, normalized to mock, are shown in the tables below the images ( n ≥ 3 for D, n ≥ 2 for G). n indicates the number of biological replicates.
Techniques Used: Generated, Infection, Staining, Microscopy, Western Blot, Standard Deviation
Figure Legend Snippet: Neutral lipid synthesis is important for efficient VACV replication. ( A, B ) Chemical inhibition of lipid droplet synthesis suppresses VACV replication. HFFs were infected with VACV in the presence or absence of 30 µM avasimibe, 125 µM T-863, or 125 µM PF-06424439. Virus titers were measured by a plaque assay at ( A ) 24 hpi (MOI = 2) and ( B ) 48 hpi (MOI = 0.01). The numbers above the bars indicate the fold reduction in VACV titers compared to vehicle ( n ≥ 3). ( C ) The inhibition of lipid droplet synthesis does not alter HFF viability. HFFs were grown in the presence or absence of 30 µM avasimibe, 125 µM T-863, or 125 µM PF-06424439 for 48 h. Cell viability was determined by trypan blue exclusion assay using a hemocytometer ( n ≥ 3). ( D-F ) Lipid droplet synthesis is important for the expression of VACV late genes. HFFs were infected with VACV (MOI = 2) that expressed Gaussia luciferase under ( D ) early (vEGLuc), ( E ) intermediate (vIGLuc), and ( F ) late (vLGLuc) promoters. A Gaussia luciferase assay was performed to measure the early, intermediate, and late gene expression at 6, 8, and 16 hpi, respectively. AraC, which inhibits VACV DNA replication and intermediate and late gene expression, was used at a concentration of 40 µg/mL as a control ( n ≥ 3). ( G, H ) Chemical inhibition of lipid droplet synthesis differentially suppresses VACV replication in transformed cells. HepG2 ( G ) and A549 ( H ) cells were infected with MOI of 0.01 of vLGLuc in the presence or absence of 30 µM avasimibe, 125 µM T-863, or 125 µM PF-06424439. A Gaussia luciferase assay was performed to measure the late gene expression at 24 hpi. AraC was used at a concentration of 40 µg/mL as a control ( n ≥ 3). ( I, J ) the inhibition of lipid droplet synthesis does not alter the viability of the transformed cells. HepG2 ( I ) and A549 ( J ) cells were grown in the presence or absence of 30 µM avasimibe, 125 µM T-863, or 125 µM PF-06424439 for 48 h. Cell viability was determined by trypan blue exclusion assay using an automated cell counter ( n ≥ 3). n indicates the number of biological replicates. For P -values, ns, P > 0.05; * P ≤ 0.05; **** P ≤ 0.0001.
Techniques Used: Inhibition, Infection, Virus, Plaque Assay, Trypan Blue Exclusion Assay, Expressing, Luciferase, Concentration Assay, Control, Transformation Assay